Atovaquone

Common brands: Mepron, Atovaquone Oral Suspension, Prednisone, Prednisone Delayed Release, Prednisone Tablets, Usp, 10 Mg

Top reporter: Glaxosmithkline Llc

Antimalarial [EPC]Antiprotozoal [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Azole Antifungal [EPC]
7,725
Total Reports
4,725
Serious Reports
1,304
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.88%)

Patient Demographics

Male
3,758
Female
2,877

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Atovaquone.

# Reaction Reports % of Total
1 OFF LABEL USE 756
9.6%
2 PYREXIA 435
5.5%
3 DIARRHOEA 415
5.3%
4 DRUG INEFFECTIVE 402
5.1%
5 NAUSEA 383
4.9%
6 PNEUMONIA 371
4.7%
7 DEATH 302
3.9%
8 FATIGUE 298
3.8%
9 DYSPNOEA 283
3.6%
10 ACUTE KIDNEY INJURY 269
3.4%
11 RASH 264
3.4%
12 VOMITING 259
3.3%
13 THROMBOCYTOPENIA 257
3.3%
14 CONDITION AGGRAVATED 252
3.2%
15 NEUTROPENIA 247
3.2%
16 FEBRILE NEUTROPENIA 236
3.0%
17 ANAEMIA 199
2.5%
18 PAIN 194
2.5%
19 PANCYTOPENIA 192
2.4%
20 SEPSIS 185
2.4%
21 RESPIRATORY FAILURE 182
2.3%
22 COVID-19 175
2.2%
23 ASTHENIA 174
2.2%
24 PLATELET COUNT DECREASED 172
2.2%
25 PRODUCT USE IN UNAPPROVED INDICATION 169
2.2%
26 HEADACHE 168
2.1%
27 COUGH 162
2.1%
28 RENAL FAILURE 154
2.0%
29 DRUG INTERACTION 144
1.8%
30 PNEUMOCYSTIS JIROVECII PNEUMONIA 142
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.